| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $10,245,500 ) |
| | 2022 | 2022 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | T9D45837 | Primary Care Training and Enhancement: Physician Assistant Rural Training Program | 00 | 1 | HRSA | 6/13/2022 | $287,432 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS077114 | Probing the structure and function of the intracellular domain of cys-loop receptors | 000 | 6 | NIH | 12/13/2021 | $382,500 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01AR068279 | Myeloid KLF2 regulation mechanisms in rheumatoid arthritis | 000 | 6 | NIH | 4/29/2022 | $333,234 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA219187 | Hedgehog/Gli1-targeted therapies to overcome ovarian cancer chemoresistance and disease recurrence | 000 | 5 | NIH | 1/4/2022 | $290,368 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA219187 | Hedgehog/Gli1-targeted therapies to overcome ovarian cancer chemoresistance and disease recurrence | 001 | 5 | NIH | 4/28/2022 | $25,811 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA232591 | MYC activation in tumor progression of neuroblastoma | 000 | 4 | NIH | 1/25/2022 | $335,731 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA232591 | MYC activation in tumor progression of neuroblastoma | 001 | 4 | NIH | 4/28/2022 | $29,841 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01HL157128 | Vascular dysfunction in coronary microcirculation | 000 | 1 | NIH | 12/10/2021 | $634,922 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS117906 | Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers | 000 | 3 | NIH | 5/27/2022 | $586,033 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01AG069333 | Mitochondrial Molecules as Therapeutic Drugs for Alzheimer's Disease | 000 | 3 | NIH | 4/5/2022 | $651,088 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R21DA053824 | Endocannabinoid system and HIV-related neuropathic pain | 000 | 2 | NIH | 6/8/2022 | $191,250 |
| | 2022 | 2022 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | H8012853 | Health Center Cluster | 01 | 13 | HRSA | 5/18/2022 | $807,963 |
| | 2022 | 2022 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | H8012853 | Health Center Cluster | 00 | 13 | HRSA | 1/6/2022 | $2,423,890 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01HL160972 | Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis | 000 | 1 | NIH | 12/13/2021 | $718,036 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA264949 | Targeting Shared Vulnerabilities in Alternate Telomere Lengthening (ALT) Cancers | 000 | 1 | NIH | 12/23/2021 | $384,099 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01AG071859 | Transcriptional Dysfunction in Dentate Gyrus Cell Types: Roles of Retinoic Acid Responsive Genes in Protection Against Alzheimer's Disease Pathogenesis | 000 | 1 | NIH | 12/23/2021 | $374,444 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R03CA256718 | "Post-translational modification of non-histone proteins as a mechanism of pMHC-I neo-ligand generation" | 000 | 1 | NIH | 3/3/2022 | $76,500 |
| | 2022 | 2022 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | D3445727 | Centers of Excellence | 00 | 1 | HRSA | 5/26/2022 | $685,999 |
| | 2022 | 2022 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | UD737639 | Nurse Education, Practice, Quality, and Retention - Interprofessional Collborative Practice | 00 | 3 | HRSA | 5/12/2022 | $494,124 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS038261 | Amygdala pain mechanisms | 001 | 23 | NIH | 12/15/2021 | $551,588 |
| | 2022 | 2022 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS038261 | Amygdala pain mechanisms | 003 | 23 | NIH | 6/8/2022 | $128,474 |
| | 2022 | 2021 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | C8E44015 | Health Center Infrastructure Support | 03 | 1 | HRSA | 5/18/2022 | $0 |
| | 2022 | 2021 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | C8E44015 | Health Center Infrastructure Support | 02 | 1 | HRSA | 5/17/2022 | $0 |
| | 2022 | 2021 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | C8E44015 | Health Center Infrastructure Support | 01 | 1 | HRSA | 3/11/2022 | $0 |
| | 2022 | 2021 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS038261 | Amygdala pain mechanisms | 002 | 22 | NIH | 6/8/2022 | -$128,474 |
| | 2022 | 2021 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01NS038261 | Amygdala pain mechanisms | 000 | 22 | NIH | 12/13/2021 | $0 |
| | 2022 | 2021 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R03NS116433 | Production and evaluation CMT2 mouse models of ATP1A1 loss-of-function-mutation using Cre-LoxP technology | 000 | 2 | NIH | 6/6/2022 | $0 |
| | 2022 | 2021 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | U01AA028957 | Medication Development for the Treatment of Alcohol Use Disorder | 000 | 2 | NIH | 3/31/2022 | $0 |
| | 2022 | 2021 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | U7716497 | Model State-Supported Area Health Education Centers | 01 | 13 | HRSA | 12/1/2021 | $0 |
| | 2022 | 2021 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | U7716497 | Model State-Supported Area Health Education Centers | 02 | 13 | HRSA | 12/9/2021 | $0 |
| | 2022 | 2021 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | U7716497 | Model State-Supported Area Health Education Centers | 03 | 13 | HRSA | 2/25/2022 | $0 |
| | 2022 | 2021 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | U1U42526 | Regional Telehealth Resource Centers | 01 | 1 | HRSA | 3/7/2022 | $0 |
| | 2022 | 2021 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | UD737639 | Nurse Education, Practice, Quality, and Retention - Interprofessional Collborative Practice | 01 | 2 | HRSA | 11/29/2021 | $0 |
| | 2022 | 2020 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01AA010114 | Neuroprotection from alcohol: Control of fetal neuron cysteine and GSH homeostasis by Cys transport/synthesis | 000 | 23 | NIH | 5/18/2022 | $0 |
| | 2022 | 2020 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA190209 | Targeting the Premetastatic Niche by Antiangiogenic Immunotherapy | 000 | 5 | NIH | 12/30/2021 | $0 |
| | 2022 | 2020 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01DK113377 | Role of gut bacteria and renal lipids in obesity-related kidney disease | 000 | 4 | NIH | 6/14/2022 | $0 |
| | 2022 | 2020 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01CA221957 | Genomic and functional characterization of a panel of neuroblastoma patient-derived xenografts and cell lines | 000 | 3 | NIH | 12/24/2021 | $0 |
| | 2022 | 2020 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R21AG061674 | Reduced DRP1 and Mitophagy in Alzheimer's Disease | 000 | 2 | NIH | 11/24/2021 | $0 |
| | 2022 | 2020 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R56NS077114 | Probing the structure and function of the intracellular domain of cys-loop receptors | 000 | 6 | NIH | 4/29/2022 | $0 |
| | 2022 | 2020 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | GA537457 | Coronavirus Telehealth Resource Centers | 04 | 1 | HRSA | 4/8/2022 | $0 |
| | 2022 | 2020 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | GA537457 | Coronavirus Telehealth Resource Centers | 03 | 1 | HRSA | 3/29/2022 | $0 |
| | 2022 | 2020 | Texas Tech University Health Sciences Center | 3601 4th Street | Lubbock | TX | 79430-0002 | LUBBOCK | USA | GA537457 | Coronavirus Telehealth Resource Centers | 05 | 1 | HRSA | 6/1/2022 | $0 |
| | 2022 | 2019 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01HL132953 | Amelioration and Reversal of Hypertension by Thioredoxin | 000 | 4 | NIH | 5/27/2022 | -$357 |
| | 2022 | 2019 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | U01AA027401 | Chemically modified minocycline for treatment of alcohol use disorder | 001 | 2 | NIH | 4/13/2022 | -$4,487 |
| | 2022 | 2019 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | U01AA027401 | Chemically modified minocycline for treatment of alcohol use disorder | 000 | 2 | NIH | 4/8/2022 | $0 |
| | 2022 | 2018 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R21AI133207 | New Therapeutic Influenza Vaccine Created by Host Cell-Restricted Attenuation | 000 | 2 | NIH | 3/7/2022 | $0 |
| | 2022 | 2018 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R21HL143030 | Water T2 as a Global Biomarker for Cardiometabolic Health - The PREMIER Study | 000 | 1 | NIH | 11/9/2021 | -$14,509 |
|
| Issue Date FY: 2021 ( Subtotal = $16,905,575 ) (Continued on the next page) |
| | 2021 | 2021 | TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER | 3601 4TH STREET | LUBBOCK | TX | 79430-0002 | LUBBOCK | USA | R01GM122759 | Integrated approaches to symport mechanisms of membrane transporters | 000 | 4 | NIH | 8/16/2021 | $325,125 |
|
